Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) — Working Capital to Net Assets Ratio
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a Working Capital to Net Assets ratio of 76.3% as of September 2025. Working capital of Rs1.14 Billion (current assets of Rs2.56 Billion minus current liabilities of Rs1.43 Billion) is measured against net assets of Rs1.49 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Aarey Drugs & Pharmaceuticals Limited to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aarey Drugs & Pharmaceuticals Limited Working Capital to Net Assets (2009–2025)
This chart shows how Aarey Drugs & Pharmaceuticals Limited's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of September 2025, the ratio stands at 76.3%, reflecting working capital of Rs1.14 Billion against net assets of Rs1.49 Billion INR. See AAREYDRUGS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Aarey Drugs & Pharmaceuticals Limited (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see AAREYDRUGS market cap.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 84.1% | Rs1.16 Billion | Rs1.38 Billion | Rs2.13 Billion | Rs968.80 Million | ▼ -3.3 pp |
| 2024 | 87.4% | Rs1.16 Billion | Rs1.33 Billion | Rs2.83 Billion | Rs1.67 Billion | ▲ +0.1 pp |
| 2023 | 87.3% | Rs1.02 Billion | Rs1.17 Billion | Rs2.71 Billion | Rs1.68 Billion | ▲ +6.2 pp |
| 2022 | 81.0% | Rs920.81 Million | Rs1.14 Billion | Rs2.19 Billion | Rs1.27 Billion | ▼ -7.6 pp |
| 2021 | 88.6% | Rs875.74 Million | Rs988.60 Million | Rs2.18 Billion | Rs1.31 Billion | ▲ +0.8 pp |
| 2020 | 87.8% | Rs810.66 Million | Rs923.46 Million | Rs1.81 Billion | Rs1.00 Billion | ▲ +0.7 pp |
| 2019 | 87.1% | Rs753.60 Million | Rs865.53 Million | Rs1.33 Billion | Rs576.32 Million | ▲ +1.0 pp |
| 2018 | 86.1% | Rs690.95 Million | Rs802.45 Million | Rs1.57 Billion | Rs881.93 Million | ▲ +11.0 pp |
| 2017 | 75.2% | Rs378.47 Million | Rs503.60 Million | Rs1.31 Billion | Rs928.34 Million | ▼ -2.5 pp |
| 2016 | 77.6% | Rs284.94 Million | Rs366.97 Million | Rs1.17 Billion | Rs882.13 Million | ▼ -4.4 pp |
| 2015 | 82.0% | Rs290.45 Million | Rs354.09 Million | Rs1.09 Billion | Rs795.40 Million | ▼ -2.9 pp |
| 2014 | 84.9% | Rs293.09 Million | Rs345.21 Million | Rs1.02 Billion | Rs723.53 Million | ▲ +7.5 pp |
| 2013 | 77.4% | Rs259.07 Million | Rs334.70 Million | Rs993.83 Million | Rs734.76 Million | ▼ -7.6 pp |
| 2012 | 85.0% | Rs278.81 Million | Rs328.12 Million | Rs818.88 Million | Rs540.07 Million | ▼ -5.3 pp |
| 2011 | 90.3% | Rs197.73 Million | Rs219.05 Million | Rs372.38 Million | Rs174.64 Million | ▲ +0.1 pp |
| 2010 | 90.1% | Rs83.01 Million | Rs92.08 Million | Rs208.39 Million | Rs125.38 Million | ▲ +17.8 pp |
| 2009 | 72.4% | Rs60.76 Million | Rs83.97 Million | Rs115.79 Million | Rs55.03 Million | — |